Evidence map›Paper›PMID 31667675›Full record

ArticleJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology2020

Hybrid PET- and MR-driven attenuation correction for enhanced

Nicolas A Karakatsanis, Ronan Abgral, Maria Giovanna Trivieri, Marc R Dweck, Philip M Robson, Claudia Calcagno, Gilles Boeykens, Max L Senders, Willem J M Mulder, Charalampos Tsoumpas and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Quantification of FDG in the spinal cord using PET/MRI.Frontiers in nuclear medicine · 2025
    Article
  4. Review
  5. PET/MR imaging of inflammation in atherosclerosis.Nature biomedical engineering · 2023
    Review
  6. Effects of dynamic [Frontiers in nuclear medicine · 2023
    Article
  7. Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?International journal of molecular sciences · 2022
    Review
  8. Assessment of different quantification metrics of [Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2022
    Article
  9. Article
  10. Iterative reconstruction incorporating background correction improves quantification of [Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  11. Assessing the qualitative and quantitative impacts of simple two-class vs multiple tissue-class MR-based attenuation correction for cardiac PET/MR.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  12. Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2020: positron emission tomography, computed tomography, and magnetic resonance.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Review
  13. Cardiac PET/MR: Are sophisticated attenuation correction techniques necessary for clinical routine assessments?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  14. Clinical perspectives for the use of total body PET/CT.European journal of nuclear medicine and molecular imaging · 2021
    Article
  15. Attenuation correction for human PET/MRI studies.Physics in medicine and biology · 2020
    Article
  16. Article
  17. PET-derived bone information from 18F-sodium fluoride: A perfect match for whole-body PET/MR attenuation correction?Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 4 countries.

Nicolas A KarakatsanisBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA. nak2032@med.cornell.edu.
Ronan AbgralBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Maria Giovanna TrivieriBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Marc R DweckBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Philip M RobsonBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Claudia CalcagnoBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Gilles BoeykensBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Max L SendersBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Willem J M MulderBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Charalampos TsoumpasBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Zahi A FayadBiomedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, 1470 Madison Ave, New York, NY, 10029, USA.
Icahn School of Medicine at Mount Sinai · USAcademic Medical Center · NL

Funding

MR/PET Imaging of coronary atherosclerosisR01HL071021 · NHLBI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI FAYAD, ZAHI A. · 2002 to 2019
$7.8M
Atherosclerosis in cocaine addiction: imaging risk with PET/MRR01DA049547 · NIDA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Nelly Alia-Klein, Zahi A. Fayad · 2022 to 2026
$3.9M
British Heart Foundation FS/14/78/31020NHLBI NIH HHS R01 HL071021NIDA NIH HHS R01 DA049547
6 · The paper itself

Abstract

backgroundThe standard MR Dixon-based attenuation correction (AC) method in positron emission tomography/magnetic resonance (PET/MR) imaging segments only the air, lung, fat and soft-tissues (4-class), thus neglecting the highly attenuating bone tissues and affecting quantification in bones and adjacent vessels. We sought to address this limitation by utilizing the distinctively high bone uptake rate constant K

methodsWe introduce 5-class K

resultsIn rabbits, we observed similar (< 1.2% mean difference) vertebral bone

conclusionsK

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsAdultAnimalsBone and BonesCarotid Artery DiseasesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedMultimodal ImagingPositron Emission Tomography Computed TomographyRabbitsSodium FluorideFluorodeoxyglucose F18RadiopharmaceuticalsSodium Fluoride18F-FDG18F-NaFattenuation correctionbone segmentationcarotidPET/MR

Identifiers

PMID31667675
PMCPMC7190435
OpenAlexW2988157818

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.